最後糖尿病護理公司
MX ˙ BMV ˙ US8753722037
SecurityMX:TNDM / Tandem Diabetes Care, Inc.
InstitutionSei Investments Co
Latest Disclosed Ownership106,598 shares
Latest Disclosed Value $ 2,343,003
Sei Investments Co reports 50.65% decrease in ownership of TNDM / Tandem Diabetes Care, Inc.

On February 13, 2026 - Sei Investments Co filed a 13F-HR form disclosing ownership of 106,598 shares of Tandem Diabetes Care, Inc. (MX:TNDM) valued at $2,343,003 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 13, 2025 disclosing 215,984 shares of Tandem Diabetes Care, Inc.. This represents a change in shares of -50.65% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F TANDEM DIABETES CARE COM NEW 875372203 106,598 -109,386 -50.65 2,343 -10.64 0.0023
2025-11-13 2025-09-30 13F TANDEM DIABETES CARE COM NEW 875372203 215,984 29,253 15.67 2,622 -24.66 0.0028
2025-08-14 2025-06-30 13F TANDEM DIABETES CARE COM NEW 875372203 186,731 62,375 50.16 3,481 46.10 0.0040
2025-05-14 2025-03-31 13F/A-1 TANDEM DIABETES CARE COM NEW 875372203 124,356 549 0.44 2,383 -46.58 0.0031
2025-05-13 2025-03-31 13F TANDEM DIABETES CARE COM NEW 875372203 123,898 91 4,440 0.0048
2025-02-11 2024-12-31 13F TANDEM DIABETES CARE COM NEW 875372203 123,807 93,256 305.25 4,460 244.32 0.0057
2024-11-12 2024-09-30 13F TANDEM DIABETES CARE COM NEW 875372203 30,551 -5,599 -15.49 1,296 -11.06 0.0017
2024-08-13 2024-06-30 13F TANDEM DIABETES CARE COM NEW 875372203 36,150 18,801 108.37 1,456 137.13 0.0021
2024-05-07 2024-03-31 13F TANDEM DIABETES CARE COM NEW 875372203 17,349 9,666 125.81 614 170.48 0.0009
2024-02-14 2023-12-31 13F TANDEM DIABETES CARE COM NEW 875372203 7,683 -33,221 -81.22 227 -73.26 0.0004
2023-11-14 2023-09-30 13F TANDEM DIABETES CARE COM NEW 875372203 40,904 20,258 98.12 850 67.79 0.0015
2023-08-11 2023-06-30 13F TANDEM DIABETES CARE COM NEW 875372203 20,646 -62,319 -75.11 507 -84.98 0.0009
2023-05-12 2023-03-31 13F TANDEM DIABETES CARE COM NEW 875372203 82,965 2,512 3.12 3,369 -6.83 0.0063
2023-02-10 2022-12-31 13F TANDEM DIABETES CARE COM NEW 875372203 80,453 -29,167 -26.61 3,616 -31.06 0.0080
2022-11-14 2022-09-30 13F TANDEM DIABETES CARE COM NEW 875372203 109,620 -6,180 -5.34 5,245 -23.48 0.0117
2022-08-15 2022-06-30 13F TANDEM DIABETES CARE COM NEW 875372203 115,800 -234,068 -66.90 6,854 -83.15 0.0148
2022-05-13 2022-03-31 13F TANDEM DIABETES CARE COM NEW 875372203 349,868 -211,195 -37.64 40,686 -51.82 0.0818
2022-02-14 2021-12-31 13F TANDEM DIABETES CARE COM NEW 875372203 561,063 -151,402 -21.25 84,451 -0.71 0.1584
2021-11-12 2021-09-30 13F TANDEM DIABETES CARE COM NEW 875372203 712,465 -4,976 -0.69 85,053 21.71 0.1784
2021-08-06 2021-06-30 13F TANDEM DIABETES CARE COM NEW 875372203 717,441 32,064 4.68 69,879 15.48 0.1549
2021-05-12 2021-03-31 13F TANDEM DIABETES CARE COM NEW 875372203 685,377 133,289 24.14 60,513 14.55 0.1525
2021-02-08 2020-12-31 13F TANDEM DIABETES CARE COM NEW 875372203 552,088 502,903 1,022.47 52,825 854.55 0.1366
2020-12-04 2020-09-30 13F/A-1 TANDEM DIABETES CARE COM NEW 875372203 49,185 793 1.64 5,534 15.63 0.0160
2020-11-06 2020-09-30 13F TANDEM DIABETES CARE COM NEW 875372203 49,188 796 5,534 13,324.6416
2020-08-17 2020-06-30 13F/A-1 TANDEM DIABETES CARE COM NEW 875372203 48,392 -11,328 -18.97 4,786 24.54 0.0149
2020-08-11 2020-06-30 13F TANDEM DIABETES CARE COM NEW 875372203 62,468 2,748 3,928 10,654.9091
2020-05-14 2020-03-31 13F TANDEM DIABETES CARE COM NEW 875372203 59,720 2,463 4.30 3,843 12.60 0.0141
2020-02-06 2019-12-31 13F TANDEM DIABETES CARE COM NEW 875372203 57,257 -2,104 -3.54 3,413 -2.60 0.0102
2019-11-12 2019-09-30 13F TANDEM DIABETES CARE COM NEW 875372203 59,361 5,584 10.38 3,504 0.95 0.0090
2019-08-14 2019-06-30 13F TANDEM DIABETES CARE COM NEW 875372203 53,777 -10,970 -16.94 3,471 -15.59 0.0113
2019-05-15 2019-03-31 13F TANDEM DIABETES CARE COM NEW 875372203 64,747 -24,229 -27.23 4,112 10.45 0.0138
2019-02-13 2018-12-31 13F TANDEM DIABETES CARE COM NEW 875372203 88,976 18,079 25.50 3,723 22.59 0.0133
2018-11-08 2018-09-30 13F TANDEM DIABETES CARE COM NEW 875372203 70,897 24,915 54.18 3,037 199.80 0.0110
2018-08-03 2018-06-30 13F TANDEM DIABETES CARE COM NEW 875372203 45,982 45,982 1,013 0.0034
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.